STOCK TITAN

Veracyte to Present at 20th Annual Needham Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Veracyte (Nasdaq: VCYT) announced that Bonnie Anderson, CEO and Chairman, will participate in a fireside chat during the 20th Annual Needham Virtual Healthcare Conference on April 13, 2021, at 2:15 p.m. ET. The live audio webcast can be accessed via Veracyte's website, and a replay will be available for 90 days post-event. Veracyte is known for its genomic diagnostics which aid in cancer diagnosis and treatment, offering tests for lung, prostate, breast, thyroid, and bladder cancers.

Positive
  • None.
Negative
  • None.

Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, announced today that Bonnie Anderson, chairman and chief executive officer, will participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, April 13, 2021 at 2:15 p.m. Eastern Time.

The link to the live audio webcast of the company’s presentation will be available by visiting Veracyte’s website at https://investor.veracyte.com/events-presentations. A replay of the webcast will be available for 90 days following the conclusion of the live presentation broadcast.

About Veracyte

Veracyte (Nasdaq: VCYT) is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company’s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company’s tests in lung cancer, prostate cancer, breast cancer, thyroid cancer, bladder cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping and renal cancer tests are in development. With Veracyte’s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide. Veracyte is based in South San Francisco, California. For more information, please visit www.veracyte.com and follow the company on Twitter (@veracyte).

FAQ

When will Bonnie Anderson participate in the Needham Virtual Healthcare Conference?

Bonnie Anderson will participate on April 13, 2021, at 2:15 p.m. ET.

How can I access the live webcast of Veracyte's presentation?

The live audio webcast can be accessed through Veracyte's official website.

What genomic tests does Veracyte offer?

Veracyte offers tests for lung, prostate, breast, thyroid, and bladder cancers.

How long will the replay of the Veracyte webcast be available?

The replay will be available for 90 days after the live presentation.

What is the stock symbol for Veracyte?

The stock symbol for Veracyte is VCYT.

Veracyte, Inc.

NASDAQ:VCYT

VCYT Rankings

VCYT Latest News

VCYT Stock Data

1.74B
76.84M
0.79%
104.45%
4%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
SOUTH SAN FRANCISCO